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Abstract
Klebsiella pneumoniae is the common cause of a global emerging infectious disease, community-acquired pyogenic liver
abscess (PLA). Capsular polysaccharide (CPS) and lipopolysaccharide (LPS) are critical for this microorganism’s ability to
spread through the blood and to cause sepsis. While CPS type K1 is an important virulence factor in K. pneumoniae causing
PLA, the role of LPS in PLA is not clear. Here, we characterize the role of LPS O antigen in the pathogenesis of K. pneumoniae
causing PLA. NTUH-K2044 is a LPS O1 clinical strain; the presence of the O antigen was shown via the presence of 1,3-
galactan in the LPS, and of sequences that align with the wb gene cluster, known to produce O-antigen. Serologic analysis
of K. pneumoniae clinical isolates demonstrated that the O1 serotype was more prevalent in PLA strains than that in non-
tissue-invasive strains (38/42 vs. 9/32, P,0.0001). O1 serotype isolates had a higher frequency of serum resistance, and
mutation of the O1 antigen changed serum resistance in K. pneumoniae. A PLA-causing strain of CPS capsular type K2 and
LPS serotype O1 (i.e., O1:K2 PLA strain) deleted for the O1 synthesizing genes was profoundly attenuated in virulence, as
demonstrated in separate mouse models of septicemia and liver abscess. Immunization of mice with the K2044 magA-
mutant (K1
2 O1) against LPS O1 provided protection against infection with an O1:K2 PLA strain, but not against infection
with an O1:K1 PLA strain. Our findings indicate that the O1 antigen of PLA-associated K. pneumoniae contributes to
virulence by conveying resistance to serum killing, promoting bacterial dissemination to and colonization of internal organs
after the onset of bacteremia, and could be a useful vaccine candidate against infection by an O1:K2 PLA strain.
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Introduction
Community-acquired pyogenic liver abscess (PLA) is an emerg-
ing infectious disease. According to recent epidemiologic studies,
80% of cases of PLA were caused by Klebsiella pneumoniae; 60% to
80% of the K. pneumoniae isolates causing these cases belonged to the
K1 capsular type, and 10% to 14% isolates belonged to the K2
capsular type in Asia [1,2]. Most PLA-associated K. pneumoniae
strains, but not strains that are not tissue-invasive, show a
hypermucoid phenotype, serum resistance, and resistance to
phagocytosis [3]. Capsular polysaccharide (CPS) has been shown
to be essential for the virulence of this pathogen [3]. magA is
predicted to be a capsular polymerase gene wzy for K1 by sequence
alignment. Mutations in magA have been shown to result in CPS
deficiency and avirulence in a mouse model of septicemia [3,4].
As the outermost components of the bacterial surface, CPS and
the O-antigen portion of the lipopolysaccharide (LPS) are among
the first bacteria-derived molecules to be encountered by the host’s
innate immune system. Both CPS and LPS components are
important pathogenic determinants in K. pneumonia-caused pneu-
monia and bacteremia [5–7], but little is known about the
virulence role of LPS in K. pneumoniae PLA.
LPS consists of three structural domains: lipid A, the core
oligosaccharide (OS), and the O antigenic polysaccharide (O-PS).
The O antigen is the outermost component of LPS and consists of a
polymer of oligosaccharide repeating units. Among clinical K.
pneumoniae isolates, the O1 antigen is the most common O antigen
[8]. The clinically prevalent O1 antigen contains two structurally
distinct O-PS domains composed of the repeat units D-galactan I
and D-galactan II. O-antigen biosynthesis is performed by the
products of the wb (rfb) gene cluster; the high chemical variability
shown by O antigens is reflected by the genetic variation in the
corresponding genes [9,10]. Genes of the wb cluster in K. pneumoniae
O1 are required for the expression of D-galactan I [11,12], but the
locations and identities of genes required for D-galactan II
biosynthesis remains unknown. The wb gene cluster contains six
genes. The wzm and wzt (formerly rfbAB) loci encode the
transmembrane and ATP-binding components of the ABC-2
transporter, respectively [13]. glf encodes a UDP-galactopyranose
mutase, which generates uridine 59-diphospho-a-D-galactofuranose
(UDP-Galf), the biosynthetic precursor of galactofuranosyl residues
[14]. The remaining three genes (wbbM, wbbN, and wbbO) encode
three galactosyltransferases and form a membrane-localized
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cluster; the WbbO gene product is the first dedicated enzyme in the
assembly pathway for the O1 antigen [16].
In the present study, we examined the distribution of O1
serotypes in PLA and non–tissue-invasive K. pneumoniae clinical
isolates; determined whether a correlation exists between O1
serotype and resistance to killing by serum; explored the role of the
O1 antigen of K. pneumoniae in the pathogenesis of PLA; and
investigated whether antiserum raised against LPS O1 could
protect against PLA-associated K. pneumoniae infection.
Results
NTUH-K2044 is a LPS O1-type strain
We isolated and analyzed the LPS of a clinical K. pneumoniae
PLA strain, NTUH-K2044, and a corresponding magA (CPS-
deficient) mutant. Based on LPS composition, the major sugar was
galactose; no glucosamine or mannose was detected. The major
sugar linkage was 1,3-galactosidic. The detailed chemical structure
of O antigens of the serotype (O1) has been identified as repeated
D-1,3-galactan polymers [12,17] Separately, analysis (using Basic
Local Alignment Search Tool (BLAST)) of the nucleotide
sequences of the wb cluster from NTUH-K2044 revealed 98.3%
sequence identity compared with the cluster from the 889/50
strain (O1:K20), but only 73.4% sequence identity compared with
the genes from the CWK47 strain (O8) [11,18]. Gene order
(synteny) and sequence similarity are poorer in comparison to the
wb clusters of isolates of other LPS serotypes. Both results
(chemical analysis of LPS and sequence analysis of wb) indicate
that NTUH-K2044 is a LPS O1-type strain.
Reactivity of antiserum from magA-mutant
hyperimmune mice against LPS O1
In order to determine the prevalence of the LPS O1-type in
clinical isolated K. pneumoniae strains, 3 primer pairs were designed
for the polymerase chain reaction (PCR) detection of O1-serotype-
synthesizing genes. Because the LPS O types of the 77 K-antigen
Klebsiella reference strains were determined previously [8], the
conserved sequences of wbbO, KP3695/wbbM, and wzm from the
889/50 strain (O1:K20) and the NTUH-K2044 strain (O1:K1)
were used to target the corresponding domains of the O1-serotype
wb cluster of K-antigen Klebsiella reference strains (Figure 1).
Among 77 K-antigen Klebsiella reference strains, we found that
63% to 73% (19/30 to 22/30) of the O1-serotype isolates and
23% (11/47) of the non–O1-serotype isolates were identified by
PCR with these primer pairs (Table 1). The primers designed for
detection of the LPS O1-type showed a limited sensitivity and
specificity. Next, we generated antiserum which was supposed to
Figure 1. Genetic organization of the wb cluster in serotype O1 K. pneumoniae strain. The PCR primer alignments and the lengths of the
amplicons (wbbO, KP3695/wbbM, and wzm) used to study the frequency of O1 type in the K. pneumoniae strains are shown. Arrows denote the
orientations of the open-reading frames.
doi:10.1371/journal.pone.0033155.g001
Table 1. LPS O1-type wb PCR of proposed O antigen type of the 77 K-antigen Klebsiella reference strains.
Serotype
* Number of tested strains O1-wb gene
wbbO (1040 bp) wbbM (1022 bp) wzm (905 bp)
O1 30 22 19 21
O2 10 5 5 5
O2ac 2 1 2 2
O3 13 0 0 0
O 4 3 000
O 5 5 000
O 7 1 000
O 8 1 000
O12 1 0 0 0
NT O
2 6 333
NT O
+ 5 211
Sensitivity (%) 73.3 63.3 70.0
Specificity (%) 75.3 71.4 74.0
*NT, nontypeable.
doi:10.1371/journal.pone.0033155.t001
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magA mutant (K1
2 O1) in mice. The reactivity to LPS O1 of the
K2044 magA-mutant hyperimmune antiserum was evaluated by
immunoblotting against the exopolysaccharide (EPS) extracts of
K-antigen Klebsiella reference strains. Antiserum against the K2044
magA mutant reacted with all of 20 randomly selected O1-serotype
isolates but with none of 20 randomly selected isolates known to
belong to other serotypes or that were not O-antigen typeable.
Therefore, the antiserum demonstrated 100% (20/20) sensitivity
and 100% (20/20) specificity against O1-type strains. Immuno-
blotting was also performed against EPS extracts of the K2044
wbbO mutant (K1 O1
2) and K2044 magA wbbO double mutant
(K1
2O1
2). No cross-reaction was seen for either mutant (Figure 2),
demonstrating that antiserum generated from the K2044 magA-
mutant hyperimmune mice is specific to LPS O1.
Prevalence of O1 antigen in K. pneumoniae clinical
isolates
We compared the distribution of O1 serotypes by immuno-
blotting of samples from 74 clinical isolates of K. pneumoniae,
including 42 PLA strains and 32 non-tissue-invasive strains. The
O1 serotype accounted for 63.5% of all clinical isolates, with
significant differences in representation among the strains that
caused PLA (38/42; 90.5%) and those that were not tissue-invasive
(9/32; 28.1%) (P,0.0001, chi-square test).
Resistance to serum killing in O1- and non–O1-serotype
Klebsiella strains
Previous study reported that the prevalence of the O1 serotype
was higher among serum-resistant strains than among serum-
sensitive strains of K. pneumoniae clinical isolates [19]. Among our K.
pneumoniae clinical isolates, 8 of 9 non–tissue-invasive O1 serotype
strains were resistant to killing by serum, whereas 1 of 9 non–
tissue-invasive strains which was not O1 serotype was resistant to
serum. Among 18 randomly selected Klebsiella K-antigen reference
strains, 9 of 9 O1-serotype strains were resistant to serum. In
contrast, 0 of 9 strains which was not O1 serotype was resistant.
The frequency of serum-resistant strains among the isolates which
were of serotype O1 (94.4%; 17/18 strains) was significantly
higher than that among the isolates which were not of serotype O1
(5.6%; 1/18 strains) (P,0.0001, chi-square test, Figure 3A and
3B). Therefore, our data showed consistent with the previous
finding and a higher frequency of serum resistance among the O1-
serotype Klebsiella isolates than among non-O1-serotype Klebsiella
isolates. We also examined the deposition of complement C3 in
these tested reference strains. However, no direct correlation
between the C3 deposition pattern and bacterial resistance was
observed in serum-resistant O1-type strains and serum-sensitive
non–O1-type strains (Figure 3C).
Characterization of the O1 deletion mutant
To generate the O1-antigen deficient mutant, a wbbO mutant of
NTUH-K2044 (O1:K1) was constructed (knock-out) by unmarked
deletion. We previously reported [20] that the chemical structure
of the CPS of K. pneumoniae NTUH-K2044 consisted of a repeated
trisaccharide [R3]-b-D-Glc-(1R4)-[2,3-(S)-pyruvate]-b-D-GlcA-
(1R4)-a-L-Fuc-(1R). Chemical structure analysis of the EPS of
the K2044 wbbO-mutant strain revealed the presence of CPS
sugars, such as fucose, glucose and glucuronic acid; galactose and
1,3-galactosidic linkages were not seen. Moreover, compared to
the parent strain, the K2044 wbbO mutant had lost its O antigen,
as determined by silver staining and by immunoblotting (Figure 4A
and 4B). Introduction into the wbbO mutant of a copy of the wbbO
gene under control of its own promoter did not restore the O
antigen production. However, the O antigen production was
restored partially by complementation with the plasmid containing
the entire wb cluster (Figure 4A and 4B). Since the wb cluster
contains the promoter for the wb operon and six genes, wzm, wzt,
glf, wbbM, wbbN, and wbbO, this result proper regulation of the
wbbO gene expression requires cis-elements within the wb cluster.
We obtained similar results with another clinically isolated O1-
type A4528 wbbO-mutant (K2 O1
2) strain (Figure 4A and 4B).
Anti-K1 reactivity was against EPS extracts of NTUH-K2044
(O1:K1) derivatives, but not against that of the unencapsulated
K2044 magA mutant or that of NTUH-A4528 (O1:K2) derivatives.
Surprisingly, anti-K2 reactivity was observed not only against the
EPS extracts of NTUH-A4528 (O1:K2) derivatives, but also
against the EPS extracts of NTUH-K2044 (O1:K1) derivatives
(Figure 4C and 4D). Apparently, the anti-K2 sera (raised against
formalin-killed whole O1:K2 bacteria) recognized both the K2
antigen and the O1 antigen (Figure 4D).
To further characterize the phenotypic changes in the wbbO
mutant in comparison with the wild-type strain, some in vitro assays
were performed. The O1 deletion mutants exhibited a mucoid
phenotype and produced amounts of CPS similar to that of the
NTUH-K2044 or the NTUH-A4528 wild-type strains (Table 2
and Table 3). As assayed in LB broth culture, the growth rate of
Figure 2. Specificity of O1-antiserum from K2044 magA mutant
hyperimmune mice. EPS were prepared from K. pneumoniae NTUH-
K2044, the K2044 wbbO mutant, the K2044 magA mutant, and the
K2044 magA wbbO double mutant strain. Extracts from normalized
bacterial suspensions (10
8 CFU) were separated by 12% SDS-PAGE and
visualized by immunoblot.
doi:10.1371/journal.pone.0033155.g002
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that of the wild-type strains. In contrast, growth of the wbbO
mutant was slower upon introduction of the wb cluster
complementation plasmid, but this effect was attributable to
carriage of the replicative TA-wb plasmid, since similar effects
were seen upon introduction of a TA-GFP expression plasmid
(Figure 5A).
Both the O and K antigens were shown to contribute
significantly to the virulence of K. pneumoniae, by conferring
protection against serum killing and phagocytosis, respectively
[3,21,22]. To test the sensitivity to the serum’s bactericidal effect of
the wbbO mutant strains, serum killing assays were performed.
Killing of the wbbO mutants by non-immunized healthy human
serum was more efficient than killing of the NTUH-K2044 or
NTUH-A4528 wild-type strain, presumably because mutants
lacked O1 antigen. The serum-sensitive phenotype in the wbbO
mutants could be partially restored by complementation with the
wb cluster (Figure 5B). The levels of C3 complement components
deposited on the NTUH-A4528 (O1:K2) wild-type strain were
much higher than those deposited on the NTUH-K2044 (O1:K1)
wild-type strain. In both backgrounds, deposition was reduced by
mutation of wbbO, and the effect was partially counteracted by
complementation with the wb cluster (Figure 5C). To test the
opsonophagocytic activity of the mutant strains, a Dictyostelium
model was used [22]. wza and wzb, which are located in the region
coding for the K2 CPS biosynthetic machinery, were deleted in
NTUH-A4528; the wza wzb double mutant then was assessed for
virulence. As expected, these mutations resulted in the loss of K2
CPS; the mutant exhibited an avirulent phenotype in a septicemia
mouse model (Table 2 and Table 3). At doses of up to 5000
Dictyostelium cells, the wbbO mutants were as resistant to
phagocytosis as the respective wild-type strains (Figure 5D). In
Figure 3. Sensitivities of the O1-type and non–O1-type Klebsiella strains to serum killing and complement C3 deposition. A and B,
serum sensitivity assays. Differences in resistance to killing by nonimmune healthy human serum between the K. pneumoniae clinical isolate non-
tissue-invasive and Klebsiella K-antigen reference strains. The data represent the means of three independent trials; the error bars represent the
standard deviations. An average survival ratio $1 corresponds to serum resistance. C, Complement C3 deposition on Klebsiella K-antigen reference
strains. Western blot analysis of complement C3 deposition on 9 serum-resistant O1-type and 9 serum-sensitive non–O1-type Klebsiella strains.
Samples were exposed to serum for 1 min.
doi:10.1371/journal.pone.0033155.g003
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mutants were more susceptible to phagocytosis by Dictyostelium cells
(Figure 5D). Thus, the O antigen confers protection against serum
killing, but not against phagocytosis.
Virulence of O1-deletion mutant during PLA-associated
K. pneumoniae infection
Upon intraperitoneal (IP) infection of mice, the wbbO mutants
had LD50 values of 1.0610
3 CFU (K2044 background) and
2.8610
4 CFU (A4528 background) (Table 3). Both wbbO mutants
were less virulent than the respective parent strains (Figure 6A).
Complementation of the wbbO mutant with the wb cluster partially
restored virulence in mice, with LD50 values (via the IP route) of
7.5610
2 CFU and 2.2610
3 CFU, respectively, for the comple-
mented strains (Table 3). When mice were challenged by
intragastric infection, the survival of the mice infected with the
A4528 wbbO mutant was increased markedly compared to that of
mice infected with the A4528 parental strain. However, the
survival of the mice was not significantly different for animals
infected with the K2044 wbbO mutant compared to the respective
parental strain (Figure 6B). To explore bacterial dissemination in
vivo, we examined the bacterial load in mice challenged with
equivalent doses (1610
3 CFU) of the wild-type strains, the wbbO
mutant strains, and the DwbbO wb cluster complementation strains.
When organs were examined in surviving animals at 24 hr after
bacterial inoculation, the mice infected with the A4528 wbbO
mutant had no detectable bacteria in the blood (P=0.028,
Figure 6C). In both genetic backgrounds, the wbbO mutants
yielded significantly fewer colony counts both in the liver and
spleen compared with the respective wild-type parent. In the
A4528 background, complementation of the wbbO mutant with the
wb cluster partially restored the colony counts in both in the liver
and spleen (Figure 6D). Previous studies revealed that TRIF- and
MyD88-dependent TLR signaling, which stimulate proinflamma-
tory cytokines TNF-alpha and IL-6, contribute to host defense
against Klebsiella infection [23]. Although the wbbO mutants
exhibited reduced lethality in the mouse model, the mutants
stimulated the proinflammatory cytokine TNF-a to levels
comparable to those resulting from infection with the wild-type
strains (Figure 6E). However, serum IL-6 concentrations were
reduced in the mice infected with the A4528 wbbO mutant group
compared to animals infected with the NTUH-A4528 wild-type
strain (P=0.011, Figure 6F). Meanwhile, infection with the wb
Figure 4. EPS phenotype of K. pneumoniae NTUH-K2044 (O1:K1), NTUH-A4528 (O1:K2), and the corresponding wbbO mutant and
wbbO complementation strains. EPS were prepared from the K. pneumoniae NTUH-K2044, NTUH-A4528, and wbbO mutants and wbbO
complementation strains in the respective genetic backgrounds. Extracts from normalized bacterial suspensions (10
8 CFU) were separated by 12%
SDS-PAGE and visualized by silver staining or immunoblotting. A and B, Silver staining and immunoblotting with K2044 magA mutant hyperimmune
O1 antiserum. C and D, Immunoblots of the same material developed with rabbit anti-K1 antiserum (Statens Serum Institute; 1:10,000) (C); rabbit anti-
K2 antiserum (Denka Seiken, 1:5,000) (D).
doi:10.1371/journal.pone.0033155.g004
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production to levels higher than those seen with the A4528 wbbO
mutant (P=0.002, Figure 6F). These data demonstrate that
mutants impaired for O1 production have decreased virulence,
with reduced bacterial colonization in organs and decreased host
inflammatory response to K. pneumoniae infection.
Protective effect of anti-O1 antibodies during K.
pneumoniae infection
To evaluate the protective efficacy of active immunization
against O1, mice were pretreated by IP injection with either
K2044 magA or K2044 magA wbbO (1610
6 CFU per dose),
administered once weekly for three weeks. On the fourth week, the
animals (in groups of 8) were challenged IP with a lethal dose of
highly virulent K. pneumoniae NTUH-K2044 or NTUH-A4528.
Seven of the 8 (87.5%) unimmunized control mice or mice
hyperimmunized with the K2044 magA-mutant (K1
2 O1) died
within 19 days of NTUH-K2044 (O1:K1) infection (P=0.2235,
Figure 7A). Within 6 days of NTUH-A4528 (O1:K2) infection,
100% of the unimmunized control mice or the mice hyperimmu-
nized with the K2044 magA wbbO double mutant (K1
2 O1
2) died.
Meanwhile, 62.5% of the mice hyperimmunized with the K2044
magA-mutant (K1
2 O1) survived without any symptoms of disease
through 28 days after challenge (P=0.0001, Figure 7A). Mice
immunized with the K2044 magA mutant (K1
2 O1) showed anti-
O1 immunoglobulin G (IgG) production by immunoblot; mice
hyperimmunized with the K2044 magA wbbO double mutant
(K1
2O1
2) did not (Figure 7B). The results of the hyperimmuni-
zation study were consistent with a separate test in which the
passive protective efficacy of O1 antiserum was tested. In the
passive immunization study, mice were pretreated with naı ¨ve or
immune mouse sera (negative and positive controls, respectively).
The in vivo protective capacity of the sera was tested using a K.
pneumoniae septicemia infection model, whereby the mice were
inoculated IP with the encapsulated K2 NTUH-A4528 strain
(1610
4 CFU). The bacterial load was determined in both the liver
and spleen at 4 h post-infection. Compared to animals pre-treated
with naı ¨ve serum, mice pretreated with K2044 magA mutant
immune mouse serum (IMS-PC) had significantly reduced
bacterial loads; mice pretreated with K2044 magA wbbO double
mutant (K1
2O1
2) immune mouse serum (IMS-NC) showed no
such reduction of bacterial load (Figure 7C). These results indicate
that in both active and passive immunization studies, O1-antigen
specific antiserum was able to reduce the bacterial dissemination
and protect the infection of encapsulated O1:K2 PLA-associated
K. pneumoniae in a mouse model of septicemia.
Discussion
In contrast to the large number of capsular types (78 K types) in
Klebsiella [24], only nine LPS O groups have been recognized,
including the serotypes O1, O2, O2ac, O3, O4, O5, O7, O8, and
O12 [8]. Hansen et al. used the inhibition enzyme-linked
immunosorbent assay (iELISA) method to characterize 638 K.
pneumoniae clinical isolates from Denmark, Spain, and the US.
Over 90% of these screened isolates were found to be positive for
O antigen, of which O1 was the most common serotype [8].
Table 2. The capsule quantification of K. pneumoniae NTUH-
K2044, NTUH-A4528, wbbO mutants and wbbO
complementation strains in the respective genetic
backgrounds and non-encapsulated mutants.
Strain Quantity (mean ± S.D.)
* -Fold
{
NTUH-K2044 19.6261.47 5.60
K2044 DwbbO 19.7560.09 5.63
K2044 DwbbO::wbbO 19.0360.94 5.43
K2044 DwbbO::TA-wb 19.2760.32 5.49
K2044 DmagA 3.5160.47 1.00
NTUH-A4528 15.9360.79 4.30
A4528 DwbbO 15.4360.59 4.17
A4528 DwbbO::TA-wb 15.7260.28 4.24
A4528 Dwza wzb 3.7060.65 1.00
*Values are the averages of triplicate samples and are given as micrograms of
uronic acid/10
9 CFU.
{Comparison based on the non-capsulated strain K2044 DmagA or A4528 Dwza
wzb.
doi:10.1371/journal.pone.0033155.t002
Table 3. Phenotypic characterization of K. pneumoniae NTUH-K2044, NTUH-A4528, wbbO mutants and wbbO complementation
strains in the respective genetic backgrounds and non-encapsulated mutants.
Strain Genotype or phenotype
* CPS K Ag LPS O1 Ag Serum resistance
{
LD50 values (CFU) of
intraperitoneal
inoculation
NTUH-K2044 wild-type/m
+ K1
+ + R ,1610
2
K2044 DwbbO wbbO/m
+ K1
+ 2 S1 610
3
K2044 DwbbO::TA-wb wild-type/m
+ K1
+ + R7 . 5 610
2
K2044 DmagA magA/m
2 K1
2 + S .1610
7
K2044 DmagA wbbO magA wbbO/m
2 K1
2 2 SN D
NTUH-A4528 wild-type/m
+ K2
+ + R ,1610
2
A4528 DwbbO wbbO/m
+ K2
+ 2 S2 . 8 610
4
A4528 DwbbO::TA-wb wild-type/m
+ K2
+ + R2 . 2 610
3
A4528 Dwza wzb wza wzb/m
2 K2
2 + ND .1610
7
*m
+, mucoid phenotype; m
2, non-mucoid phenotype.
{R, resistance; S, sensitive.
ND, not determined.
doi:10.1371/journal.pone.0033155.t003
Lipopolysaccharide O1 in K. pneumoniae PLA
PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e33155Figure 5. Sensitivities of the wbbO-mutant strains to serum killing, complement C3 deposition, and phagocytosis by Dictyostelium.
A, Growth rates in LB broth of the K. pneumoniae wild-type, wbbO mutants, wbbO complementation strains, and the wbbO mutants with the GFP
expression plasmid strains . The data represent the means of three independent trials; the error bars represent the standard deviations.
** P,0.01 by
Student’s t test (comparing the wb cluster-complemented wbbO mutant vs. the wild-type or wbbO mutant strains). B, Serum sensitivity assays of
resistance to killing by nonimmune healthy human serum, comparing the wild-type, the wbbO mutant, and wbbO complementation strains. The data
represent the means of three independent trials; the error bars represent the standard deviations. The average survival ratio $1 corresponds to
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the limited availability of anti-O sera. Instead, Gierczynski et al.
have tested clinical K. pneumoniae isolates for the presence of 7
(waaA, waaE, waaL, waaQ, waaZ, waaX, and uge) genes of the waa
and 4 (wbdA, wbdC, manB, and wbbO) genes of the wb clusters for
LPS biosynthesis [25]. No apparent correlation between genotype
and serotype was observed, which is consistent with our current
findings. The primers used in the present study showed a limited
specificity to genes coding for biosynthesis of LPS O1. This lack of
O1 specificity may reflect the genetic variation that exist in the wb
cluster among strains of O1, O2 and O2ac serotypes, since these
LPS species share similar O antigenic repeats, with all containing
the D-galactan I subunit [12].
The absence of the O1 antigen in the LPS of wbbO mutants of
NTUH-K2044 or NTUH-A4528 was confirmed by silver staining
and immunoblotting. In contrast to clinical K. pneumoniae O1
strains, the O1-antigen–deficient strain was sensitive to serum
killing. This result is consistent with the previous demonstration
that a high-molecular-weight fraction of Klebsiella O1 LPS is
responsible for the resistance of the bacterium to serum killing
[26]. Previous studies also reported that complement C3 binds to
the O1-antigen polysaccharide units of LPS on smooth K.
pneumoniae strains [27]. This conclusion explains why the levels of
C3 complement components deposited on wbbO mutants were
reduced compared to the wild-type parent. Removal of the O1
antigen presumably changes the sites where binding occurs,
consistent with changes to the extent of opsonization [28]. In
earlier studies, O1-antigen–deficient mutants were generated
either in K. pneumoniae O1:K2 strain 52145 or 43816 by insertional
mutagenesis of the wbbM or wbbO gene, respectively [5,6]. In
contrast to our results, there were no changes in serum sensitivity
in those mutant strains lacking the O1 antigen [5,6]. However,
those researchers were unable to restore the wild-type phenotype
of the O1-deficient mutant with a plasmid containing the wb
cluster [5,6], suggesting the presence of a secondary mutations in
those O1-deficient mutants. The wbbO mutants were attenuated in
in vivo proliferation and ability to deeply disseminate to mouse
organs during the first 24 h of infection. Stimulation of
proinflammatory cytokine IL-6 in mice infected with the A4528
wbbO mutant was decreased compared to that seen in mice
infected with the parental strain. Moreover, the LD50 of the wbbO
mutant was 10-fold or 200-fold higher than that of the virulent
NTUH-K2044 (O1:K1) or NTUH-A4528 (O1:K2) strains,
respectively, after IP injection in mice. These results suggest that
the O1-deficient mutant is less virulent than the parental strain
during K. pneumoniae infection.
Trautmann et al. found no significant differences in a
comparison of the O-serotype distributions of Klebsiella among
invasive versus noninvasive isolates [29]. Their invasive strains
were obtained from blood cultures (n=79), from open-lung–biopsy
specimens (n=7), and from patients’ abdominal cavities during
septic surgery (n=13) [29]. In the present study, the O1 serotype
represented 28.1% of clinical non–tissue-invasive K. pneumoniae
isolates, a prevalence similar to that seen for the O1-type strains in
these earlier serologic analysis of Klebsiella clinical isolates [8,29].
Nonetheless, the highly prevalence (90.5%) of the O1 serotype in
PLA strains indicates that the O1-type strains are predominant
among K. pneumoniae isolates causing PLA. The prevalence of
serum resistance was higher in the O1-serotype isolates than in
non–O1-serotype isolates. Meanwhile, loss of the O1 antigen
influenced the resistance to serum, suggesting that a correlation
exists between the O1 serotype and the ability of K. pneumoniae to
resist the bactericidal effects of human serum.
Earlier results showed that the LPS O1 antigen is masked in
those K. pneumoniae strains harboring CPS types K1, K10, or K16;
K antigen and LPS are exposed together at the cell surface in K.
pneumoniae O1 strains harboring CPS types K2, K7, K19, K21,
K22, or K66 [27]. Both of anti-O1 sera and anti-K2 sera
increased the surface hydrophobicity of the O1:K2 strain, in which
the K2 capsule and the O1 LPS are surface-exposed. However,
anti-O1 sera did not increase the hydrophobicity of the O1:K1
strain, in which the O1 LPS was masked by the K1 capsule. Only
anti-K1 sera increased the hydrophobicity of the O1:K1 strain
[30]. We also found that commercial rabbit anti-K2 antisera can
recognize both of the K2 and the O1 antigens. In response to
infection by a virulent O1:K2 strain, high-dose pretreatment with
anti-LPS O1 monoclonal antibody significantly reduced bacterial
dissemination to various organs and histologic pulmonary
alterations [31]. Clements et al. used K. pneumoniae B5055
(O1:K2), a pneumonia strain, and proved that immunization with
its purified LPS can protect mice against lethal challenge with
either O1:K2 or O2:K1 K. pneumoniae infection [32]. In our results,
mice immunized with the K2044 magA mutant (K1
2 O1) generated
antiserum against LPS O1, and this antiserum had significantly
protective efficacy against the PLA-associated O1:K2 strain, but
not the PLA-associated O1:K1 strain. In both active and passive
immunization studies, O1-antigen specific antiserum was able to
limit the growth and reduce the bacterial dissemination of
encapsulated O1:K2 PLA-associated K. pneumoniae in a mouse
model of septicemia. Therefore, LPS O1 antigen could be a useful
vaccine candidate conferring broad cross-protection against K.
pneumoniae infection from the K2 capsular type, in which LPS O1
antigen is exposed on the bacterial surface. However, O1 antigen
would not provide protection against K. pneumoniae infection of the
capsular type (e.g., K1) that mask the O1 antigen.
In summary, LPS O1 is more prevalent in PLA strains than in
non–tissue-invasive strains. The frequency of serum resistance is
higher in the O1-serotype isolates than in the non–O1-serotype
isolates. Mutation of the genes coding for biosynthesis of the O1
antigen changes serum resistance; reduces bacterial dissemination
and colonization into deep organs, and decreases the inflamma-
tory response to K2 PLA-associated K. pneumoniae infection.
Immunization of mice against LPS O1 provides protection against
infection with a K2 PLA-associated K. pneumoniae strain, but not
against infection with a K1 PLA-associated K. pneumoniae strain.
Materials and Methods
Ethics statement
All animal procedures were approved under application
number 20060139 of the Institutional Animal Care and Use
Committee (IACUC) of the National Taiwan University College
of Medicine (NTUCM). Procedures were consistent with the
recommendations of the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health and Taiwan’s Animal
Protection Act. These studies used BALB/cByl mice that were
serum resistance.
** P,0.01 or
* P,0.05 by Student’s t test (comparing wbbO mutant strains vs. the wild-type or the wb cluster-complemented wbbO
mutant). C, Western blot analysis of complement C3 deposition. Samples were exposed to serum for 1 min. D, Resistance to phagocytosis in the K.
pneumoniae wild-type and wbbO mutant strains by plaque assays. Pictured assay used 5000 Dictyostelium cells per test. Non-encapsulated mutants
were permissive for Dictyostelium growth and were used as positive controls.
doi:10.1371/journal.pone.0033155.g005
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PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e33155Figure 6. Survival rate and immune response in K. pneumoniae-inoculated mice. A and B, Eight mice per group were infected with the wild-
type and the wbbO mutant strains at an intraperitoneal (IP) dose of 1610
3 CFU/animal or an intragastrical (IG) dose of 1610
6 CFU/animal. Survival of
mice was monitored for 4 (IP) or 6 (IG) weeks. &, NTUH-K2044; %, K2044 wbbO; m, NTUH-A4528; n, A4528 wbbO mutant (K2044 wbbO vs. parent,
P=0.0002 (IP) and P=0.4417 (IG); A4528 wbbO vs. parent, P,0.0001 (IP) and P=0.0129 (IG); log-rank test). C to F, Equivalent doses (1610
3 CFU) of the
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animal care facilities of the Laboratory Animal Center at the
NTUCM. Throughout the studies, mice were provided with free
access to food and water.
Bacterial strains and culture conditions
A total of 74 clinical isolates of K. pneumoniae were collected from
1997 to 2003 in the National Taiwan University Hospital as
described previously [33]. Among the 74 isolates obtained from
patients with septicemia, 42 strains were obtained from patients
displaying PLA and were designated as the PLA strains. While
some of these cases were complicated by metastatic meningitis
and/or endophthalmitis, all incidences of PLA were confirmed by
sonography-guided aspiration or surgical drainage at the time of
collection. Among the remaining 32 patients who did not display
clinical symptoms of liver abscess, meningitis, or endophthalmitis,
diagnoses included pancreatitis, biliary tract stones with cholan-
gitis, or gall bladder empyema; the resulting isolates were
designated as non-tissue-invasive strains. Seventy-seven K-antigen
Klebsiella reference strains were obtained from the Statens Serum
Institute (Copenhagen, Denmark). K. pneumoniae and E. coli strains
were cultured in Luria-Bertani (LB) medium supplemented with
wild-type, the wbbO mutant, and the wbbO mutant with the wb cluster complementation were inoculated into mice (4 mice per group) by IP
injection. Surviving animals were sacrificed at 24 hours after challenge. Bacterial loads were measured in the blood (C), liver, and spleen (D); TNF-a (E)
and IL-6 (F) levels were measured in the serum. Log10 CFU was standardized per 0.1 gram wet organ weight. IL-6 and TNF-alpha levels were measured
by ELISA. Data are presented as means 6 standard deviations. ND, not detected.
** P,0.01 and
* P,0.05 by Student’s t test (wbbO mutant group vs.
wild-type group or the wbbO mutant with the wb cluster complementation group).
doi:10.1371/journal.pone.0033155.g006
Figure 7. Survival rate and immune response in K2044 magA mutant hyperimmune and virulent K1/K2 K. pneumoniae-challenged
mice. A, Survival of K2044 magA mutant hyperimmune mice challenged with NTUH-K2044 (O1:K1) or NTUH-A4528 (O1:K2). Mice (8 per group) were
inoculated three times by once-weekly IP injections with 1610
6 CFU of K2044 magA-mutant or K2044 magA wbbO double mutant. Age-matched,
unimmunized control mice were inoculated with saline. At the fourth week, immunized groups were challenged with NTUH-K2044 or the NTUH-
A4528 (1610
3 CFU per animal, IP). Survival was assessed for 28 days following infection. %, K2044 magA mutant hyperimmune, NTUH-K2044
challenge.; &, nonimmune, NTUH-K2044 challenge; n, K2044 magA mutant hyperimmune, NTUH-A4528 challenge;m, nonimmune, NTUH-A4528
challenge; X, K2044 magA wbbO double mutant hyperimmune, NTUH-A4528 challenge. By log-rank test: P=0.2235, K2044 magA/NTUH-K2044 vs.
nonimmune/NTUH-K2044; P,0.0001, K2044 magA/NTUH-A4528 vs. nonimmune/NTUH-A4528 or K2044 magA wbbO/NTUH-A4528. B, Immune
response of anti-O1 IgG in K2044 magA-mutant hyperimmune mice. Immunoblots developed with rabbit anti-K1 antiserum (purchased from Statens
Serum Institute, 1:10,000) (a), K2044 magA mutant immune mouse serum (1:2500) (b) or K2044 magAwbbO double mutant immune mouse serum
(1:500) (c). C, O1-Ag-specific antibodies reduce growth of NTUH-A4528 (O1:K2) K. pneumoniae in mice. Groups of 4 BALB/c mice were treated with one
of the following: naı ¨ve mouse serum (NMS), K2044 magA mutant immune mouse serum (IMS–positive control, IMS-PC), K2044 magAwbbO double
mutant immune mouse serum (IMS–negative control, IMS-NC). One hour after injection, mice were infected with 1610
4 CFU the NTUH-A4528 by
intraperitoneal injection. Four hours after infection, the number of bacteria in the liver and spleen were determined. Log10 CFU was standardized per
0.1 gram wet organ weight. The black and white bars represent the means for each group for liver and spleen, respectively; error bars indicate
standard deviations.
** P,0.01 by Student’s t test (IMS-PC vs. IMS-NC or NMS).
doi:10.1371/journal.pone.0033155.g007
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50 mg/mL kanamycin. Bacterial strains and plasmids used in this
study are listed in Table S1.
LPS-PCR genotyping
In order to detect genes coding for the LPS O1 type,
polymerase chain reaction (PCR) was performed using primer
pairs specific for wbbO, KP3695/wbbM, and wzm. Primers used in
this study are listed in Table S2. PCR was performed as described
elsewhere [3]. Briefly, 3 mL of overnight-cultured bacterial broth
was added to 10 mL of water and boiled for 15 min to release
DNA template. Reaction mixtures containing primers (0.4 mmol/
L each), dNTPs (0.1 mmol/L each), Taq polymerase (2 U; New
England Biolabs), and 13 mL of the above DNA template was
incubated at 96uC for 3 min, followed by 30 cycles of 96uC for
30 s, 52uC for 15 s, and 72uC for 1 min.
Characterization of LPS
The exopolysaccharide (EPS) extracts (containing both CPS and
LPS) were purified by a modified hot water–phenol extraction
method [4]. Briefly, 1 mL of bacteria cultured overnight in LB
were harvested and resuspended in 150 mL of water. An equal
volume of hot phenol (pH 6.6; Amresco) was added, and the
mixture was vortexed vigorously. The mixture was then incubated
at 65uC for 20 min, followed by chloroform extraction and
centrifugation. Samples were separated by 12%-sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then
silver-stained [34]. The chemical structures of O polysaccharides
in the wild-type NTUH-K2044 strain and K2044 wbbO mutant
were analyzed by gas chromatography/mass spectrometry after
derivatization with trimethylsilyl for sugar composition and with
permethylated alditol acetates for sugar linkages.
Immunoblots
The extracts of EPS from each strain were separated by 12%
SDS-PAGE and blotted to a Hybond C nitrocellulose membrane
(Amersham, Little Chalfont, UK). The K1 antisera were
purchased from Statens Serum Institute (Denmark) and the K2
antisera were purchased from Denka Seiken (Tokyo, Japan) and
diluted 1/10,000 or 1/5,000 for immunoblots. To obtain sera
from K2044 magA-mutant hyperimmune mice (for O1 typing) or
K2044 magA wbbO double mutant hyperimmune mice, mice were
immunized intraperitoneally with 1610
6 colony-forming units
(CFU) of K2044 magA mutant (K1
2O1) or K2044 magA wbbO
double mutant (K1
2O1
2). The mice were immunized three times
with a single inoculation per week and were sacrificed on the
fourth week. The resulting mouse sera were diluted 1/2500 or 1/
500 for immunoblots.
Serum killing assays
The survival of exponential-phase bacteria in nonimmune
human serum was measured as previously described [3]. Briefly, a
log-phase inoculum of 2.5610
4 CFU was mixed at a 1:3 vol/vol
ratio with mixed nonimmune human serum donated by 5 healthy
volunteers. The final mixture, comprising 75% nonimmune serum
by volume, was incubated at 37uC for 3 h. The colony count was
determined by plating of serial dilutions on LB agar, and the
average survival ratio was plotted. An average survival ratio $1
corresponds to serum resistance.
Complement C3 deposition assays
The complement C3 deposition assay was performed by an
established method [28]. Briefly, a bacterial suspension
(2610
8 CFU/mL) was opsonized with 25% serum at 37uC for
1 min. Bacteria were washed (with centrifugation and resuspen-
sion) three times with 16PBS. The final pellet was resuspended in
50 mM carbonate-bicarbonate buffer, pH 9.0, containing 1 M
NH4OH, to disrupt ester bonds between C3 fragments and the
bacterial surface. After 2 h at 37uC, the C3 fragment suspension
was reduced with 10 mM dithiothreitol in 1% SDS at 37uC for
1 h and alkylated with 22 mM iodoacetamide at 37uC for 1 h.
After 12% SDS-PAGE, the western blot analysis was performed.
The membranes were incubated sequentially with anti-human
complement C3 (1:2,000; Biogenesis) and rabbit horseradish
peroxidase-conjugated anti-goat IgG antibody (1:10,000; Jackson
ImmunoResearch), and developed with an enhanced chemilumi-
nescence system (Amersham Biosciences).
Gene deletion and complementation
K. pneumoniae mutated in genes coding for K antigen (magA or
wza wzb), O antigen (wbbO), or both systems (magA wbbO) were
constructed using the previously described unmarked deletion
method [33], which employs electroporation and selection with a
temperature-sensitive vector pKO3-Km containing flanking
regions for each target gene. The primer pairs for the deletion
constructs are listed in Table S2. For complementation, the intact
wbbO gene was amplified by PCR and cloned into the intergenic
region of the two open reading frames (ORFs), pgpA and yajO,i na
pKO3-Km-pgpA-yajO recombinant vector [35]. The wb cluster was
amplified by PCR and cloned into the PCRII-TOPO vector
(Promega). The recombinant TA-wb plasmid was transformed into
the wbbO mutant strains by electroporation. All of the deletion and
complementation constructs were confirmed by PCR and
sequence determination. All sequence data for the K. pneumoniae
NTUH-K2044 chromosome has been deposited by Wu et al.
(Genbank accession number AP006725) [36].
Extraction and quantification of CPS
The bacterial CPS was extracted by using a method described
by Domenico [37]. Briefly, 500 ml of overnight-grown bacteria was
mixed with 100 ml of 1% Zwittergent 3–14 (Sigma-Aldrich,
Milwaukee, WI) in 100 mM citric acid (pH 2.0) and then
incubated at 50uC for 20 min. After centrifugation, 250 ml of the
supernatant was transferred to a new tube, and the CPS was
precipitated with 1 ml of absolute ethanol. The mixture was
incubated at 4uC for 20 min. After centrifugation, the pellet was
dried and dissolved in 200 ml of distilled water, and then 1,200 ml
of 12.5 mM tetraborate in concentrated H2SO4 was added. The
mixture was vigorously mixed and boiled for 5 min. After cooling,
20 ml of 0.15% 3-hydroxydiphenol (Sigma-Aldrich, Milwaukee,
WI) was added. The tubes were shaken and the absorbance at
520 nm was measured. Uronic acid content was determined from
a standard curve of D-glucuronic acid (Sigma-Aldrich, Milwaukee,
WI) and expressed as micrograms per 10
9 CFU.
Bacterial growth assays
An 18-h culture of each strain was used to inoculate each 5-ml
tube at a ratio of 1:100. Each culture was grown at 37uC for 3 h in
LB or LB supplemented with the appropriate antibiotics. After
incubation, growth was monitored spectrophotometrically at
600 nm every hour.
Dictyostelium phagocytosis by plaque assays
D. discoideum AX-2 cells were grown as previously described
[22]. Briefly, D. discoideum AX-2 cells were grown at 23uC in HL5
medium. To test Dictyostelium growth on Klebsiella mutant strains,
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1200, 2500, or 5000 Dictyostelium cells were added to the bacterial
lawn, and the formation of phagocytic plaques was observed after
5 days.
Mouse inoculation experiments
Virulence assay. Virulence was evaluated by mortality in
two different models: a murine model of septicemia generated by
IP injection, and a murine model of liver abscess generated by
intragastric injection. Groups of five-week-old female BALB/cByl
mice were infected IP or intragastrically with isogenic K. pneumoniae
NTIH-K2044 or NTUH-A4528 mutants in 0.1 mL of 0.95%
saline (10
2–10
7 CFU; 4 mice for each dose). The exact inoculation
dose was confirmed by serial dilution and plating to LB agar. Mice
were monitored for 4 or 6 weeks in IP or intragastric inoculation
experiments (respectively); upon death or after sacrifice of
surviving mice (at the end of the 4 or 6 weeks), the liver and
brain were removed for histopathologic examination. The 50%
lethal dose (LD50) was calculated as described by Reed and
Muench [38]. To determine the bacterial load in vivo, the same
inoculation dose (1610
3 CFU) of each strain (4 mice for each
group) was administered by IP injection. Surviving animals were
sacrificed at 24 hours after challenge; blood and organ
homogenates (including liver and spleen) were cultured for
quantification of CFU. The number of CFU detected in the
organs was standardized per 0.1 gram wet organ weight. Sera were
collected at 24 h; IL-6 and TNF-alpha levels were measured by
ELISA (R&D Systems, Minneapolis, MN).
Protection study. For active immunization, five-week-old
BALB/cByl mice were immunized three times by once-weekly IP
injection with the indicated dose of the lived K2044 magA-mutant
or K2044 magA wbbO double mutant, and were challenged at the
fourth week. Age-matched, unimmunized control mice were
inoculated with saline (8 mice per group). After 4 weeks,
immunized and unimmunized control mice were challenged
with 1610
3 CFU of NTUH-K2044 (O1:K1) or NTUH-A4528
(O1:K2); this dose is greater than the LD50 value. The challenged
mice were observed for 28 days for mortality and clinical signs.
Survival was analyzed by Kaplan-Meier analysis with a log-rank
test; a P value,0.05 was considered to be statistically significant.
For passive protection, 100 mL of immunized and unimmunized
control mice sera was administered to five-week-old BALB/cByl
mice by IP injection. One hour after serum injection, the mice
were infected by intraperitoneal inoculation with 1610
4 CFU of
NTUH-A4528 (O1:K2). Four hour after infection, the mice were
euthanized and bacterial counts from liver and spleen were
determined.
Statistical Analyses
Data are presented as means 6 standard deviations (SDs).
Statistical significance of comparisons of mean values was assessed
by a two-tailed Student’s t test using Prism 5 (Graphpad) software.
Prevalence was analyzed by chi-square test using SPSS version
12.0 software. Survival was analyzed by Kaplan-Meier analysis
with a log-rank test. P values of ,0.05 were considered significant.
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